Olsutamig is a bivalent humanized IgG4κ monoclonal antibody inhibitor targeting FOLH1/PSMA and CD3E. It is capable of binding simultaneously to PSMA on tumor cell surfaces and CD3E on T cell surfaces, leading to significant activation of T cells and the specific destruction of prostate cancer cells.
Olsutamig
Copy Product Info
🥰Excellent
Catalog No. T9901A-1889
Olsutamig is a bivalent humanized IgG4κ monoclonal antibody inhibitor targeting FOLH1/PSMA and CD3E. It is capable of binding simultaneously to PSMA on tumor cell surfaces and CD3E on T cell surfaces, leading to significant activation of T cells and the specific destruction of prostate cancer cells.
Olsutamig
Cas No. 3034664-43-9
Pack Size
Price
USA Stock
Global Stock
Quantity
1 mg
Inquiry
Inquiry
Inquiry
5 mg
Inquiry
Inquiry
Inquiry
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Olsutamig is a bivalent humanized IgG4κ monoclonal antibody inhibitor targeting FOLH1/PSMA and CD3E. It is capable of binding simultaneously to PSMA on tumor cell surfaces and CD3E on T cell surfaces, leading to significant activation of T cells and the specific destruction of prostate cancer cells.
Chemical Properties
Cas No.
3034664-43-9
Storage & Solubility Information
Storage
store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.
Calculator
Dilution Calculator
Reconstitution Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Olsutamig | purchase Olsutamig | Olsutamig cost | order Olsutamig